⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for sarcomatous mesothelioma

Every month we try and update this database with for sarcomatous mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by SurgeryNCT00003723
Malignant Mesot...
gemcitabine hyd...
18 Years - SWOG Cancer Research Network
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaNCT00354393
Malignant Mesot...
Cisplatin
Methotrexate
Vinorelbine dit...
Adjuvant therap...
Conventional su...
Neoadjuvant The...
3-dimensional c...
Intensity-modul...
- 75 YearsThe Cleveland Clinic
AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaNCT01105390
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
rilotumumab
cisplatin
pemetrexed diso...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaNCT00227630
Malignant Mesot...
cisplatin
pemetrexed diso...
adjuvant therap...
conventional su...
neoadjuvant the...
radiation thera...
- 69 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Gefitinib in Treating Patients With Malignant MesotheliomaNCT00025207
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI)
S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by SurgeryNCT00003723
Malignant Mesot...
gemcitabine hyd...
18 Years - SWOG Cancer Research Network
Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107NCT00898547
Malignant Mesot...
immunoenzyme te...
laboratory biom...
18 Years - Alliance for Clinical Trials in Oncology
Surgery and Photodynamic Therapy in Treating Patients With Malignant MesotheliomaNCT00054002
Malignant Mesot...
adjuvant therap...
conventional su...
porfimer sodium
18 Years - Roswell Park Cancer Institute
S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By SurgeryNCT00243074
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
cediranib malea...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryNCT00309946
Advanced Malign...
Epithelial Meso...
Localized Malig...
Recurrent Malig...
Sarcomatous Mes...
cediranib malea...
18 Years - National Cancer Institute (NCI)
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural MesotheliomaNCT00334594
Malignant Mesot...
Cisplatin
Pemetrexed
Therapeutic con...
Radiotherapy
18 Years - 69 YearsSwiss Group for Clinical Cancer Research
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant MesotheliomaNCT00821860
Malignant Mesot...
Metastatic Canc...
talc
therapeutic tho...
therapeutic vid...
18 Years - Papworth Hospital NHS Foundation Trust
Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural MesotheliomaNCT00354393
Malignant Mesot...
Cisplatin
Methotrexate
Vinorelbine dit...
Adjuvant therap...
Conventional su...
Neoadjuvant The...
3-dimensional c...
Intensity-modul...
- 75 YearsThe Cleveland Clinic
Capecitabine in Treating Patients With Malignant MesotheliomaNCT00004183
Malignant Mesot...
capecitabine
18 Years - Alliance for Clinical Trials in Oncology
Erlotinib in Treating Patients With Malignant Mesothelioma of the LungNCT00039182
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
erlotinib hydro...
laboratory biom...
- National Cancer Institute (NCI)
PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By SurgeryNCT00365053
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
belinostat
laboratory biom...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant MesotheliomaNCT00027703
Advanced Malign...
Epithelial Meso...
Localized Malig...
Recurrent Malig...
Sarcomatous Mes...
gemcitabine hyd...
cisplatin
bevacizumab
placebo
laboratory biom...
18 Years - National Cancer Institute (NCI)
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By SurgeryNCT00309946
Advanced Malign...
Epithelial Meso...
Localized Malig...
Recurrent Malig...
Sarcomatous Mes...
cediranib malea...
18 Years - National Cancer Institute (NCI)
Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.NCT00107432
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
Stage IA Malign...
Stage IB Malign...
Stage II Malign...
Stage III Malig...
Stage IV Malign...
sorafenib tosyl...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line ChemotherapyNCT01085630
Malignant Mesot...
pemetrexed diso...
clinical observ...
18 Years - Alliance for Clinical Trials in Oncology
AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaNCT01105390
Advanced Malign...
Epithelial Meso...
Recurrent Malig...
Sarcomatous Mes...
rilotumumab
cisplatin
pemetrexed diso...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: